ABOS
Price:
$2.22
Market Cap:
$133.38M
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.[Read more]
Industry
Biotechnology
IPO Date
2021-07-01
Stock Exchange
NASDAQ
Ticker
ABOS
According to Acumen Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 17.37. This represents a change of -32.17% compared to the average of 25.61 of the last 4 quarters.
The mean historical Current Ratio of Acumen Pharmaceuticals, Inc. over the last ten years is 18.60. The current 17.37 Current Ratio has changed 9.24% with respect to the historical average. Over the past ten years (40 quarters), ABOS's Current Ratio was at its highest in in the September 2021 quarter at 137.62. The Current Ratio was at its lowest in in the March 2020 quarter at 0.
Average
18.60
Median
19.01
Minimum
5.35
Maximum
38.60
Discovering the peaks and valleys of Acumen Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 453.13%
Maximum Annual Current Ratio = 38.60
Minimum Annual Increase = -40.19%
Minimum Annual Current Ratio = 5.35
Year | Current Ratio | Change |
---|---|---|
2023 | 19.01 | -17.64% |
2022 | 23.08 | -40.19% |
2021 | 38.60 | 453.13% |
2020 | 6.98 | 30.46% |
The current Current Ratio of Acumen Pharmaceuticals, Inc. (ABOS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
26.90
5-year avg
18.60
10-year avg
18.60
Acumen Pharmaceuticals, Inc.’s Current Ratio is less than Terns Pharmaceuticals, Inc. (21.02), greater than X4 Pharmaceuticals, Inc. (6.07), greater than Day One Biopharmaceuticals, Inc. (4.09), greater than HOOKIPA Pharma Inc. (3.86), greater than Amylyx Pharmaceuticals, Inc. (4.66), greater than Inozyme Pharma, Inc. (9.84), greater than Mereo BioPharma Group plc (6.07),
Company | Current Ratio | Market cap |
---|---|---|
21.02 | $549.60M | |
6.07 | $109.78M | |
4.09 | $1.25B | |
3.86 | $159.50M | |
4.66 | $161.36M | |
9.84 | $312.42M | |
6.07 | $664.26M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Acumen Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Acumen Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Acumen Pharmaceuticals, Inc.'s Current Ratio?
How is the Current Ratio calculated for Acumen Pharmaceuticals, Inc. (ABOS)?
What is the highest Current Ratio for Acumen Pharmaceuticals, Inc. (ABOS)?
What is the 3-year average Current Ratio for Acumen Pharmaceuticals, Inc. (ABOS)?
What is the 5-year average Current Ratio for Acumen Pharmaceuticals, Inc. (ABOS)?
How does the current Current Ratio for Acumen Pharmaceuticals, Inc. (ABOS) compare to its historical average?